GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (STU:NOTA) » Definitions » Deferred Policy Acquisition Costs

Novartis AG (STU:NOTA) Deferred Policy Acquisition Costs


View and export this data going back to . Start your Free Trial

What is Novartis AG Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Novartis AG (STU:NOTA) Business Description

Industry
Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.